Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
To cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 7 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Mar 2026, Apr 2026, Jun 2026, Jul 2026, Sep 2026 and Oct 2026.
- Largest single sale: $572K (14,982 shares) of Immunovant, Inc. on Jun 26, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Immunovant, Inc. (IMVT) | Chief Legal Officer | Dec 18, 2024 | Oct 9, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 7, 2026, Immunovant, Inc.: sold 1,327 shares for $43K, to cover taxes. 1 filing: 1
- Sep 23, 2026, Immunovant, Inc.: sold 2,846 shares for $103K, to cover taxes. 1 filing: 1
- Jul 8, 2026, Immunovant, Inc.: sold 1,206 shares for $48K, to cover taxes. 1 filing: 1
- Jun 26, 2026, Immunovant, Inc.: sold 17,824 shares for $683K, no plan disclosed; 17,824 shares acquired by exercising options. 1 filing: 1
- Jun 18, 2026, Immunovant, Inc.: sold 2,634 shares for $93K, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.